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Viral regulation of cell death 
The cell autonomous immune response is multi-
faceted and forms an important first line of defence 
upon pathogen infection (Randow et al. 2013). A ma-
jor element of this response is the induction of cell sui-
cide pathways, which contribute to the limiting of in-
fection through elimination of a replication niche. 
Consequently, pathogens have evolved a multitude of 
strategies to intercept this pathway to promulgate in-
fection. Human Cytomegalovirus (HCMV), a human 
herpes virus, is no exception and expresses an armoury 
of gene functions that promote viability (McCormick 
2008). However, a key biological characteristic of 
HCMV is the ability to establish lifelong latent infec-
tions which are hallmarked by limited viral gene ex-
pression and no viral replication (Dupont & Reeves 
2016).  
 One of the first host cell 'trip wires' is the de-
tection of the pathogen upon entry into the cell. Impor-
tantly, we and others have shown that the virus must 
ameliorate this response for the establishment of non-
lytic but functional infections (Chan et al. 2010, 
Reeves et al. 2012). Crucially, the absence of many 
viral anti-apoptotic functions during this phase of in-
fection has rendered the virus dependent on the activa-
tion of key cellular functions. The favoured model pro-
poses that HCMV engages with the cell and triggers 
the activation of cell death pathways but, via concomi-
tant activation of the survival pathways, the outcome is 
positive for the virus, resulting in long term infection 
of these cells. 
 For HCMV, and the establishment of latency 
in CD34+ cells, the activation of ERK-MAPK signal-
ling appears to be a crucial event (Reeves et al. 
2012). In the current issue, Kew et al. (2017) have in-
vestigated this in more detail and demonstrate that 
ERK activation underpins a multi-faceted survival re-
sponse encompassing post translational down-
regulation of pro-apoptotic Bim and the induction ELK
-1 transcriptional activity. Importantly, the activation 
of ERK is required to prevent the consequence of a 
concomitant activation of the pro-apoptotic protein, 
Bak, by viral infection. The challenge now is to fully 
understand how these multiple events tip the balance 
in favour of survival in the infected cells. For instance, 
deletion of ELK-1 was not overly deleterious to 
CD34+ cells until the cells were subsequently stressed 
by viral infection, supporting a role in acute survival 
responses rather than long term homeostasis of viabil-
ity. 
 The question remains as to why this is impor-
tant. Clearly, the immediacy of understanding how 
pathogens promote cell survival has direct impact on 
our understanding of the complexity of the host-
pathogen interaction. However, the wider implications 
are driven by a desire to decipher the biology of the 
cell. Dysregulated cell death underpins the pathogene-
sis of many infectious and non-infectious diseases and 
thus, understanding how these pathways are regulated 
can give new insight and, potentially, new hope for 
treatment of many complex diseases. For example, a 
proof of principle study showed that a CMV-encoded 
RNA that maintained energy production in virally in-
fected cells (Reeves et al. 2007) could be used to pro-
tect rodents from the symptoms of Parkinson's disease 
(Kuan et al. 2012). Ultimately, viruses are assiduous 
molecular biologists - experts at hijacking, partitioning 
or re-directing cellular functions. It is hoped that, as 
we further unravel and define the complexity of the 
host-pathogen interaction, we will provide the founda-
tion to interrogate host cell biology and reveal the 
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